BFF investor Alken is ready to back a domestic rescue solution for the firm. Shares fell 86% this year amid banking rule changes. Nicolas Walewski said, "I'd be ready to increase it again if I knew there is institutional support in Italy for a domestic solution." Many investors are watching.
BFF has been grappling since mid-2024 with the impact of tighter banking rules establishing when a loan should be classed as impaired and the pace at which it should be covered in full by provisions against potential losses.
Sign up here.
Its shares are down 86% year-to-date.
BFF finances public sector suppliers by buying invoices off them. It diversified its business with the acquisition of DepoBank in 2021, adding depositary and payment services.
"I have strong faith in the business model. I have long experience in investing in these kind of specialty finance businesses. If done rigorously, profitability can be very high," said Nicolas Walewski, CIO of AFFM.
BFF faces a modest capital shortfall by 2028.
It has received several expressions of interest from potential investors and is currently talking to the U.S. firm Cerberus with a view to bolstering its longer-term finances.
Pharmaceutical businessman Del Bono last week launched an appeal to keep control of BFF in Italian hands, calling for a group of domestic investors to subscribe to a capital increase which would avoid the need for support from Cerberus.
"I welcome Del Bono's proposal," Walewski told Reuters.
"BFF's businesses include handling billions of euros in mutual funds' deposits and a key payments infrastructure used by other Italian banks. This is a strategic asset for Italy and, as a foreign shareholder, I would be reassured by a domestic core investor base," he added.
BFF had no immediate comment.
Alken owns slightly more than 2% of BFF, having halved its stake earlier this year due to market volatility.
"I'd be ready to increase it again if I knew there is institutional support in Italy for a domestic solution," Walewski said.
